Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
ISS01 - Industry Supported Symposium: Current and Emerging Treatments for Patients with ALK+ NSCLC – ARIAD Pharmaceuticals Inc.
- Type: Industry Supported Symposium
- Track:
- Presentations: 5
- Moderators:C. Zielinski
- Coordinates: 12/04/2016, 12:00 - 13:30, Strauss 3
-
+
ISS01.01 - Welcome & Introduction
12:00 - 12:05 | Author(s): C. Zielinski
- Abstract
No abstract available for this presentation
-
+
ISS01.02 - ALK Inhibitors: Current Treatments and Sequencing
12:05 - 12:30 | Author(s): C. Zielinski
- Abstract
No abstract available for this presentation
-
+
ISS01.03 - The Future of ALK Inhibitors: How the Treatment Paradigm May Change
12:30 - 12:55 | Author(s): D..R. Camidge
- Abstract
No abstract available for this presentation
-
+
ISS01.04 - Will Mutation Testing be Standard in the Resistant Setting?
12:55 - 13:20 | Author(s): P. Jänne
- Abstract
No abstract available for this presentation
-
+
ISS01.05 - Summary and Conclusions
13:20 - 13:30 | Author(s): C. Zielinski
- Abstract
No abstract available for this presentation
-
+
SC14 - Immunotherapy of NSCLC
- Type: Science Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:N. Rizvi
- Coordinates: 12/06/2016, 11:00 - 12:30, Hall C2
-
+
SC14.01 - Immunotherapy in the First-Line Setting of Advanced NSCLC
11:00 - 11:20 | Author(s): R. Herbst
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC14.02 - Immunotherapy in the Second-Line Setting of Advanced NSCLC
11:20 - 11:40 | Author(s): L. Paz-Arez
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC14.03 - Combination Immunotherapy - Basic Considerations and First Outcomes
11:40 - 11:55 | Author(s): D.R. Spigel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC14.04 - The CD47 Macrophage Checkpoint as a New Immunotherapy Target
11:55 - 12:10 | Author(s): B. Sikic
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC14.05 - Tobacco Use and Immunotherapy
12:10 - 12:25 | Author(s): A. Dingemans
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SC22 - Selection and Monitoring of Patients for Immune Checkpoint Inhibitors
- Type: Science Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:G.V. Scagliotti
- Coordinates: 12/06/2016, 16:00 - 17:30, Hall C8
-
+
SC22.04 - How Can Immunotherapy Be Implemented in a Cost-Effective Strategy?
17:00 - 17:20 | Author(s): C. Zielinski
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PR04 - Press Conference: Advanced Care
- Type: Press Conference
- Track:
- Presentations: 5
- Moderators:C. Zielinski
- Coordinates: 12/07/2016, 10:30 - 11:45, Schubert 1
-
+
PR04.01 - Health-Related Quality of Life for Pembrolizumab vs Chemotherapy in Advanced NSCLC with PD-L1 TPS ≥50%: Data from KEYNOTE-024
10:30 - 10:30 | Author(s): J.R. Brahmer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR04.02 - OAK, a Randomized Ph III Study of Atezolizumab vs Docetaxel in Patients with Advanced NSCLC: Results from Subgroup Analyses
10:30 - 10:30 | Author(s): S.M. Gadgeel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR04.03 - Durvalumab in ≥3rd-Line Locally Advanced or Metastatic, EGFR/ALK Wild-Type NSCLC: Results from the Phase 2 ATLANTIC Study
10:30 - 10:30 | Author(s): M.C. Garassino
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR04.04 - Multicentric French Harmonization Study for PD-L1 IHC Testing in NSCLC
10:30 - 10:30 | Author(s): J. Adam
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR04.05 - A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): With Translational Research (TR) Biopies
10:30 - 10:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.